Cardiovascular Health

Mar 30, 2026

Can Exercise Restore HRV After Bariatric Surgery?

Bariatric surgery can improve metabolism while cardiac autonomic recovery lags. Four RCTs tested exercise for HRV, but results remain unresolved.

bariatric surgery autonomic dysfunction heart rate variability

Read article →

Mar 30, 2026

Morning Blood Pressure Surge: Does Exercise Timing Help?

Morning versus evening HIIT did not change the morning blood pressure surge in a small trial. Training type, chronotype, and diet may matter more.

morning blood pressure surge mbps exercise timing

Read article →

Mar 30, 2026

Blood Pressure Apps: Useful Tools, Unproven Treatment

Do blood pressure apps work? Trials find small systolic drops, but clinician support rather than software alone may explain the benefit and limit long-term value.

blood pressure hypertension digital health

Read article →

Mar 29, 2026

Can Four Health Texts Lower Blood Pressure? PUSHME Says No

The PUSHME trial tested four weekly health texts in 401 people with hypertension. Blood pressure did not improve overall—here's what did.

blood pressure hypertension behavioral intervention

Read article →

Mar 28, 2026

Tirzepatide and SGLT2 Inhibitors Show an AF Signal

Can tirzepatide and SGLT2 inhibitors reduce atrial fibrillation burden? New data link metabolic therapy to fewer AF procedures, but trials must confirm it.

tirzepatide atrial fibrillation glp-1 agonists

Read article →

Mar 28, 2026

How SGLT2 Inhibitors Protect Failing Hearts Beyond Blood Sugar

SGLT2 inhibitors cut heart-failure risk beyond glucose control. What trials, remodeling data, mechanisms, safety limits, and cardio-oncology gaps show.

sglt2 inhibitors autophagy heart failure

Read article →

Mar 27, 2026

Why Standing Breaks May Not Fully Offset Sitting’s Vascular Effects

Three hours of sitting can impair popliteal artery function. Small trials suggest active leg exercise may help more than standing breaks.

standing desk endothelial function popliteal artery

Read article →

Mar 27, 2026

Butyrate and Transplant Hearts: A Promising Cell Study

Butyrate improved mitochondrial measures in ischemic human heart cells, but this transplant-preservation study does not support supplements yet.

butyrate short-chain fatty acids gut microbiome

Read article →

Mar 27, 2026

GLP-1 Drugs and Heart Failure: What an NNT of 80 Means

GLP-1 drugs reduce heart failure events modestly overall, with stronger signals in obesity. See what the NNTs, limits, and next-generation drugs mean.

glp-1 agonists semaglutide tirzepatide

Read article →

Mar 26, 2026

Bempedoic Acid vs. Statins: Does Each LDL Drop Protect Equally?

Bempedoic acid appears to match statins per mmol/L of LDL reduction, but its smaller LDL drop limits real-world cardiovascular protection.

bempedoic acid statin intolerance ldl cholesterol

Read article →

Mar 23, 2026

HFpEF Exercise: What Training Can—and Cannot—Do

HFpEF exercise training improves fitness and quality of life, but evidence does not yet show fewer deaths or hospitalizations. Here's what the trials show.

hfpef sglt2 inhibitors heart failure

Read article →

Mar 21, 2026

GLP-1 Drugs and Stroke: What the Evidence Actually Shows

Do GLP-1 drugs lower stroke risk? Randomized trials show fewer ischemic strokes in high-risk type 2 diabetes, while hemorrhagic and obesity data remain uncertain.

glp-1 semaglutide ischemic stroke

Read article →

Page 1 of 2Next →